Marex Group plc Ordinary Shares (MRX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Marex Group plc Ordinary Shares stock (MRX) is currently trading at $38.86. Marex Group plc Ordinary Shares PE ratio is 8.24. Marex Group plc Ordinary Shares PS ratio (Price-to-Sales) is 0.88. Analyst consensus price target for MRX is $52.00. WallStSmart rates MRX as Hold.
- MRX PE ratio analysis and historical PE chart
- MRX PS ratio (Price-to-Sales) history and trend
- MRX intrinsic value — DCF, Graham Number, EPV models
- MRX stock price prediction 2025 2026 2027 2028 2029 2030
- MRX fair value vs current price
- MRX insider transactions and insider buying
- Is MRX undervalued or overvalued?
- Marex Group plc Ordinary Shares financial analysis — revenue, earnings, cash flow
- MRX Piotroski F-Score and Altman Z-Score
- MRX analyst price target and Smart Rating
Marex Group
📊 No data available
Try selecting a different time range
MRX Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Marex Group plc Ordinary Shares (MRX)
MRX trades at a significant discount to its Graham intrinsic value of $200.77, offering a 80% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Marex Group plc Ordinary Shares (MRX) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in return on equity, price/sales, eps growth. Concerns around revenue growth. Fundamentals are solid but monitor weak areas for improvement.
Marex Group plc Ordinary Shares (MRX) Key Strengths (5)
Every $100 of shareholder equity generates $28 in profit
Paying less than $1 for every $1 of annual revenue
Earnings per share surging 72.90% year-over-year
71.49% of shares held by major funds and institutions
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Marex Group plc Ordinary Shares (MRX) Areas to Watch (4)
Revenue declining -51.40%, a shrinking business
Decent operational efficiency, solid but not exceptional
Fairly priced relative to book value
Decent profitability, keeps $11 per $100 revenue
Marex Group plc Ordinary Shares (MRX) Detailed Analysis Report
Overall Assessment
This company scores 65/100 in our Smart Analysis, earning a C+ grade. Out of 9 metrics analyzed, 5 register as strengths (avg 9.4/10) while 4 fall into concern territory (avg 4.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Return on Equity, Price/Sales, EPS Growth. Valuation metrics including Price/Sales (0.88) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 27.50%. Growth metrics are encouraging with EPS Growth at 72.90%.
The Bear Case
The primary concerns are Revenue Growth, Operating Margin, Price/Book. Some valuation metrics including Price/Book (2.01) suggest expensive pricing. Growth concerns include Revenue Growth at -51.40%, which may limit upside. Profitability pressure is visible in Operating Margin at 19.50%, Profit Margin at 10.70%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 27.50% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at -51.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Return on Equity, Price/Sales) and negatives (Revenue Growth, Operating Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
MRX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
MRX's Price-to-Sales ratio of 0.88x sits near its historical average of 0.89x (43th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 26% below its historical high of 1.19x set in Mar 2026, and 45% above its historical low of 0.61x in Jun 2024.
WallStSmart Analysis Synopsis
Data-driven financial summary for Marex Group plc Ordinary Shares (MRX) · FINANCIAL SERVICES › CAPITAL MARKETS
The Big Picture
Marex Group plc Ordinary Shares faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 2.9B with 51% decline year-over-year. Profit margins of 10.7% are healthy, with room for further expansion as the business scales.
Key Findings
ROE of 27.5% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Revenue contracted 51% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Margin expansion: can Marex Group plc Ordinary Shares push profit margins above 15% as the business scales?
Sector dynamics: monitor CAPITAL MARKETS industry trends, competitive moves, and regulatory changes that could impact Marex Group plc Ordinary Shares.
Bottom Line
Marex Group plc Ordinary Shares faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 12:58:59 PM
About Marex Group plc Ordinary Shares(MRX)
NASDAQ
FINANCIAL SERVICES
CAPITAL MARKETS
USA
Marex Group plc is a prominent global commodities brokerage and risk management firm, specializing in trading, clearing, and advisory services across vital sectors including metals, energy, and agricultural commodities. With a strong emphasis on leveraging advanced technology and comprehensive market expertise, Marex caters to a diverse range of clients, from corporations and financial institutions to hedge funds, all while prioritizing transparency and customized solutions. As a publicly traded entity, Marex is dedicated to enhancing operational efficiencies and expanding its market reach, solidifying its status as a critical player in the commodities trading arena and striving to deliver sustainable value to its shareholders.